Self-injected contraceptives: does the investment reflect women’s preferences?

Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected. Substantial research and advocacy investments have been made to promote roll-out of DMPA-SC across s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Shannon N., Magalona, Sophia, Zimmerman, Linnea A., OlaOlorun, Funmilola, Omoluabi, Elizabeth, Akilimali, Pierre, Guiella, Georges, Gichangi, Peter, Anglewicz, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289037/
https://www.ncbi.nlm.nih.gov/pubmed/35835480
http://dx.doi.org/10.1136/bmjgh-2022-008862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289037/
https://www.ncbi.nlm.nih.gov/pubmed/35835480
http://dx.doi.org/10.1136/bmjgh-2022-008862

Ejemplares similares